Home > List All Publishers > Venture Planning Group

Venture Planning Group

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries. The company’s services include:

Market Intelligence Surveys

Opportunities Analyses

New Technology/Product Assessments

Acquisitions/Joint Venture Evaluations

During the course of numerous proprietary single-client consulting assignments and over 10
0 multi-client studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

List of reports from Venture Planning Group

2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ... \| more...	$5,400.00
2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ... \| more...	$5,400.00
2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ... \| more...	$5,400.00
2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ... \| more...	$6,700.00
2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ... \| more...	$5,400.00
2012 UK Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ... \| more...	$5,400.00
2012 US Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and ... \| more...	$8,700.00
Strategic Implications of Technological and Market Trends for the US Diagnostics Industry 4/17/2012 \| published by: Venture Planning Group ... and export? How will the future technological advances affect the major market segments? Which companies will enter the market and which will not survive? These and other key strategic issues facing decision-makers are explored in ... \| more...	$4,850.00
2012 Italy Blood Banking Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... market impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Italian blood banks hospitals, and commercial laboratories. Annual ... \| more...	$5,400.00
The 2012 Blood Banking Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks 3/28/2012 \| published by: Venture Planning Group The report identifies the major opportunities for blood banking instruments, consumables, and auxiliary products; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers. \| more...	$950.00
The 2012 Leading Flavor and Fragrance Companies Financial Analyses 3/28/2012 \| published by: Venture Planning Group ... the analysis provides: Sales estimates by product category and geographic region. Five-year sales and operating profit performance. The companies analyzed in the report: Firmenich, Frutarom, Givaudan, T. Hasegawa, IFF, Mane, Robertet, Sensient, Symrise, and Takasago. \| more...	$2,450.00
The 2012 Top 10 World’s Leading Flavor and Fragrance Companies 3/28/2012 \| published by: Venture Planning Group ... competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report’s major objectives include: To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, ... \| more...	$14,200.00
The 2012 Coagulation Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks 3/28/2012 \| published by: Venture Planning Group The report identifies major opportunities for coagulation instrument and consumable suppliers, proposes “ideal” product models with tentative prices and operating characteristics, and suggests alternative market penetration strategies. \| more...	$950.00
The 2012 Clinical Chemistry and Immunodiagnostics Markets:Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks 3/28/2012 \| published by: Venture Planning Group The report identifies product development opportunities for clinical chemistry and immunodiagnostic instrument and reagent suppliers, and suggests alternative market penetration strategies. \| more...	$1,500.00
The 2012 Rabies Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country 3/28/2012 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume ... \| more...	$3,850.00
The 2012 Rhinovirus Diagnostics Market: US, Europe, JapanTest Volume and Sales Forecasts by Country 3/28/2012 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs Also, the report examines the ... \| more...	$3,850.00
The 2012 Rotavirus Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country 3/28/2012 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition ... \| more...	$3,850.00
The 2012 RSV Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country 3/28/2012 \| published by: Venture Planning Group ... etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: -Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each ... \| more...	$3,850.00
The 2012 Rubella Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country 3/28/2012 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition ... \| more...	$3,850.00
The 2012 Leading Diagnostics Imaging Companies Facilities and Employees 3/28/2012 \| published by: Venture Planning Group ... facilities in the U.S. and abroad. New plants under construction. U.S. and international work force size and distribution. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. \| more...	$1,850.00
The 2012 Leading Flavor and Fragrance Companies Major Facilities and Employees 3/28/2012 \| published by: Venture Planning Group For each company, the report provides: Production, compounding, creative, and R&D facilities by country. Workforce size. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and Takasago. \| more...	$1,850.00
The 2012 Leading Agrochemical Companies R&D Expenditures and Major Programs 3/28/2012 \| published by: Venture Planning Group ... each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. \| more...	$1,650.00
The 2012 Top 10 World’s Leading Food and Beverage Companies 3/28/2012 \| published by: Venture Planning Group ... competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report’s major objectives include: To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, ... \| more...	$13,800.00
The 2012 UK Hematology and Flow Cytometry Markets 3/28/2012 \| published by: Venture Planning Group ... technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in UK hospitals and commercial laboratories. Annual placements and ... \| more...	$5,500.00
The 2012 Italian Hematology and Flow Cytometry Markets 3/28/2012 \| published by: Venture Planning Group ... technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in Italian hospitals and commercial laboratories. Annual placements and ... \| more...	$5,500.00

< prev 5 6 7 8 9 10 11 12 13 14 next >